We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
(+5.4%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASRT
Assertio
ASRT
|
+$3.68M |
| 2 |
Red Robin
RRGB
|
+$3.46M |
| 3 |
Intapp
INTA
|
+$3.34M |
| 4 |
O-I Glass
OI
|
+$3.16M |
| 5 |
PDF Solutions
PDFS
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$4.8M |
| 2 |
Target Hospitality
TH
|
+$4.6M |
| 3 |
PDS Biotechnology
PDSB
|
+$4.36M |
| 4 |
Digi International
DGII
|
+$4.3M |
| 5 |
KLX Energy Services
KLXE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25% |
| 2 | Technology | 21.39% |
| 3 | Industrials | 20.38% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Energy | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Stagwell
STGW
$2.24B
| $2.28M | 0.45% |
+306,802
| New | +$2.14M |
|
77
Archrock
AROC
$5.85B
| $2.27M | 0.45% |
+232,679
| New | +$2.28M |
|
78
NerdWallet
NRDS
$638M
| $2.26M | 0.44% |
+139,626
| New | +$2.1M |
|
79
Wabash National
WNC
$522M
| $2.26M | 0.44% |
91,714
+18,796
| +26% | +$488K |
|
80
CBIZ
CBZ
$2.96B
| $2.25M | 0.44% |
45,532
-15,735
| -26% | -$758K |
|
81
NeoGenomics
NEO
$2.1B
| $2.25M | 0.44% |
+128,972
| New | +$1.84M |
|
82
Immersion
IMMR
$249M
| $2.22M | 0.44% |
248,403
+19,487
| +9% | +$147K |
|
83
Huron Consulting
HURN
$2.44B
| $2.22M | 0.44% |
27,627
-18,697
| -40% | -$1.36M |
|
|
ISEE
84
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.19M | 0.43% |
90,079
-10,192
| -10% | -$223K |
|
85
Oceaneering
OII
$4.87B
| $2.17M | 0.43% |
123,247
+52,003
| +73% | +$1M |
|
|
VTYX
86
DELISTED
Ventyx Biosciences
VTYX
| $2.17M | 0.43% |
64,733
-194
| -0.3% | -$7.54K |
|
|
OSG
87
DELISTED
Overseas Shipholding Group Inc.
OSG
| $2.14M | 0.42% |
547,994
-94,294
| -15% | -$340K |
|
88
Comfort Systems
FIX
$59.9B
| $2.14M | 0.42% |
14,642
-1,466
| -9% | -$190K |
|
89
IBEX
IBEX
$491M
| $2.13M | 0.42% |
87,099
+15,509
| +22% | +$415K |
|
90
Bowman Consulting
BWMN
$479M
| $2.11M | 0.41% |
73,548
| – | – |
|
|
ALTR
91
DELISTED
Altair Engineering Inc
ALTR
| $2.11M | 0.41% |
+29,277
| New | +$1.73M |
|
92
Academy Sports + Outdoors
ASO
$2.96B
| $2.11M | 0.41% |
32,336
+3,601
| +13% | +$212K |
|
93
TG Therapeutics
TGTX
$7.63B
| $2.11M | 0.41% |
140,035
-25,412
| -15% | -$386K |
|
94
Aldeyra Therapeutics
ALDX
$95.9M
| $2.1M | 0.41% |
211,388
+13,160
| +7% | +$93K |
|
95
Astronics
ATRO
$3.72B
| $2.09M | 0.41% |
+187,688
| New | +$2.1M |
|
96
Badger Meter
BMI
$4.05B
| $2.08M | 0.41% |
17,073
+1,891
| +12% | +$221K |
|
97
Aaon
AAON
$7.77B
| $2.07M | 0.41% |
+32,082
| New | +$1.76M |
|
98
Duolingo
DUOL
$5.9B
| $2.06M | 0.4% |
+14,436
| New | +$1.48M |
|
99
RadNet
RDNT
$5.51B
| $2.04M | 0.4% |
+81,549
| New | +$1.77M |
|
100
ATI
ATI
$31.3B
| $2.04M | 0.4% |
+51,700
| New | +$1.95M |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q1 2023 Portfolio in Review
As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.
- EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
- EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
- EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
- EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
- EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
- EAM Investors opened 139 new positions and closed 144 in Q1 2023.
- EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.
Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.